Veredus Laboratories Confirms VereFlu™ Lab-on-Chip Detects the Current Subtype of Avian Flu H7N9 in Addition to All Other Human Flu SubtypesVereFlu™ is based on STMicroelectronics’ industry-proven Lab-on-Chip platform
Veredus Laboratories today announced that the current version of VereFlu detects the current subtype of H7N9 (Avian Flu) that is responsible for the Flu outbreak in China. H7N9 is the latest mutation to cause concern and increased surveillance in the region. Launched in 2008 and built on the STMicroelectronics lab-on-chip platform, VereFlu run on Veredus’ VerePLEXTM biosystem is the market’s first test to integrate two powerful molecular biological applications, Polymerase Chain Reaction (PCR) and a microarray, onto a Lab-on-Chip platform.
“After learning of the outbreak in China, we have confirmed in-silico1 that our current VereFlu influenza panel is able to detect the subtype of H7N9 responsible for this outbreak in addition to other human Flu A and B infections,” said Rosemary Tan, chief executive officer of Veredus. “This confirms our vision when we designed the panel for the need to have a multiplexed molecular test to detect not only the typical seasonal influenza subtypes but also novel emerging subtypes, including the current H7N9 subtype, capable of making the jump from animals to humans. Our customers can be assured that with VereFlu they are able to detect H7N9 and we are able to deliver immediately a fast, reliable surveillance system that can be deployed to help monitor the current situation.”
Veredus Laboratories Pte Ltd was founded in 2003 and launched its first products in 2005. Veredus is a Singapore-based majority-owned subsidiary of STMicroelectronics (NYSE: STM), a global semiconductor leader serving customers across the spectrum of electronics applications.
Veredus specializes in the development, manufacture, and marketing of innovative multiplexed molecular solutions in the clinical, specialty, and custom testing markets based on STMicroelectronics’ proprietary Lab-on-Chip platform. The Lab-on-Chip platform, marketed as the VerePLEXTM biosystem, combines Micro-Electro-Mechanical-Systems (MEMS) with micro-fluidics to integrate multiplexed DNA amplification with microarray detection for rapid, cost-effective, and accurate analysis of biological materials.
ST is a global leader in the semiconductor market serving customers across the spectrum of sense and power and automotive products and embedded processing solutions. From energy management and savings to trust and data security, from healthcare and wellness to smart consumer devices, in the home, car and office, at work and at play, ST is found everywhere microelectronics make a positive and innovative contribution to people's life. By getting more from technology to get more from life, ST stands for life.augmented.
In 2012, the Company’s net revenues were $8.49 billion. Further information on ST can be found at www.st.com
For further information, please contact:
Director, Sales and Marketing
Veredus Laboratories Pte Ltd
Mobile: +65 9431 3790